Automated Nucleic Acid Extraction Devices Market Opportunities and Strategies to 2034

This report describes and explains the automated nucleic acid extraction devices market and covers 2019-2024, termed the historic period, and 2024-2029, 2034F termed the forecast period. The report evaluates the market across each region and for the major economies within each region.

The global automated nucleic acid extraction devices market reached a value of nearly $5.93 billion in 2024, having grown at a compound annual growth rate (CAGR) of 12.08% since 2019. The market is expected to grow from $5.93 billion in 2024 to $9.94 billion in 2029 at a rate of 10.88%. The market is then expected to grow at a CAGR of 10.57% from 2029 and reach $16.43 billion in 2034.

Growth in the historic period resulted from the rising R&D spending in life sciences, increased prevalence of infectious diseases, increasing cancer screening and biomarker discovery and rising demand for personalized medicine. Factors that negatively affected growth in the historic period were high equipment cost and mixing efficiency.

Going forward, growing investments in biopharmaceutical manufacturing, favorable government initiatives, increasing demand for molecular diagnostics and expanding genomic research activities will drive the growth. Factor that could hinder the growth of the automated nucleic acid extraction devices market in the future include increasing regulatory scrutiny, high competition and impact of trade war and tariff.

North America was the largest region in the automated nucleic acid extraction devices market, accounting for 34.78% or $2.06 billion of the total in 2024. It was followed by Asia-Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the automated nucleic acid extraction devices market will be Asia-Pacific and Western Europe where growth will be at CAGRs of 12.63% and 10.84% respectively. These will be followed by Eastern Europe and North America where the markets are expected to grow at CAGRs of 10.62% and 9.91% respectively.

The global automated nucleic acid extraction devices market is fairly concentrated, with large players operating in the market. The top 10 competitors in the market made up 31.55% of the total market in 2024. Thermo Fisher Scientific Inc. was the largest competitor with a 8.11% share of the market, followed by F. Hoffmann-La Roche AG with 7.49%, QIAGEN N.V. with 3.18%, The Merck Group, with 3.00%, Becton Dickinson and Company, with 217%, Analytik Jena GmbH+Co. KG with 1.90%, Tecan Group Ltd. with 1.48%, Promega Corporation with 1.47%, Bruker Corporation (ELITechGroup) with 1.38% and Hamilton Company with 1.37%.

The automated nucleic acid extraction devices market is segmented by type into instruments, kits and consumables. The instruments market was the largest segment of the automated nucleic acid extraction devices market segmented by type, accounting for 42.05% or $2.49 billion of the total in 2024. Going forward, the kits segment is expected to be the fastest growing segment in the automated nucleic acid extraction devices market segmented by type, at a CAGR of 12.34% during 2024-2029.

The automated nucleic acid extraction devices market is segmented by product into fully automated and semi-automated. The fully automated market was the largest segment of the automated nucleic acid extraction devices market segmented by product, accounting for 65.40% or $3.88 billion of the total in 2024. Going forward, the fully automated segment is expected to be the fastest growing segment in the automated nucleic acid extraction devices market segmented by product, at a CAGR of 12.61% during 2024-2029.

The automated nucleic acid extraction devices market is segmented by end user into hospitals, diagnostic centers, forensic laboratories, pharmaceutical and biotechnology companies and academic research institutes. The pharmaceutical and biotechnology companies market was the largest segment of the automated nucleic acid extraction devices market segmented by end user, accounting for 30.49% or $1.8 billion of the total in 2024. Going forward, the hospitals segment is expected to be the fastest growing segment in the automated nucleic acid extraction devices market segmented by end user, at a CAGR of 11.29% during 2024-2029.

The top opportunities in the automated nucleic acid extraction devices markets segmented by type will arise in the instruments segment, which will gain $1.5 billion of global annual sales by 2029. The top opportunities in the automated nucleic acid extraction devices markets segmented by product will arise in the fully automated segment, which will gain $3.14 billion of global annual sales by 2029. The top opportunities in the automated nucleic acid extraction devices markets segmented by end user will arise in the pharmaceutical and biotechnology companies segment, which will gain $1.22 billion of global annual sales by 2029. The automated nucleic acid extraction devices market size will gain the most in the USA at $1.06 billion.

Market-trend-based strategies for the automated nucleic acid extraction devices market include focus on advancing fully automated, maxi-scale DNA purification technologies, improved workflow consistency through automated pipetting, integration of novel chemistries and ITP technology to enhance automated nucleic acid extraction from challenging samples, integrated platform streamlines diagnostic workflows.

Player-adopted strategies in the automated nucleic acid extraction devices market include focus on expanding their business expertise through new launches and through strategic partnerships.

To take advantage of the opportunities, the analyst recommends the automated nucleic acid extraction devices market companies to focus on fully automated maxi-scale systems to strengthen competitive position, focus on fully automated maxi-scale systems to strengthen competitive position, focus on fully automated maxi-scale systems to strengthen competitive position, focus on high molecular weight dna extraction for advanced genomic applications, focus on kits segment to maximize long-term growth potential, focus on kits segment to maximize long-term growth potential, expand in emerging markets, continue to focus on developed markets, provide competitively priced offerings, continue to use b2b promotions, focus on diagnostic centers to maximize growth potential.